A federal judge has thrown out patents protecting Allergan’s blockbuster dry-eye drug Restasis, and has criticised its related deal with a Native American tribe. In the ruling US Circuit Judge ...

Late last week, Allergan announced it had sold a group of US patents for its $1.5 billion-a-year ophthalmology blockbuster Restasis (cyclosporine) to the Saint Regis Mohawk Tribe. In the bizarre ...